Reduction of nitric oxide release from alveolar macrophages by a lipocortin peptide
Nitric oxide (NO), produced by alveolar macrophages (AM) is used as a marker of respiratory tract inflammation. Lipocortin 1 (Lc-1) is an anti-inflammatory, glucocorticoid-inducible protein. The current aims were to determine whether (a) an Lc-1-derived peptide, Ac2-26, inhibited lipopolysaccharide...
Saved in:
Main Authors: | A. M. Kamal (Author), T. D. Tetley (Author), I. R. Witherden (Author), S. F. Smith (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1998-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lack of involvement of lipocortin 1 in dexamethasone suppression of IL-1 release
by: E. F. Morand, et al.
Published: (1993) -
The effect of lipocortin 1 on neutrophil deformability
by: E. M. Drost, et al.
Published: (1996) -
Inhibitory Action of Daunorubicin on Lipopolysaccharide-Stimulated Inducible-Type Nitric Oxide Synthase Induction in Alveolar Macrophages
by: Fumiaki Saito, et al.
Published: (2005) -
The Effect of Steroid Treatment on Lipocortin Immunoreactivity of Rat Brain
by: K. G. Go, et al.
Published: (1994) -
Nitric oxide releasing-dendrimers: an overview
by: Antonio Carlos Roveda Júnior, et al.
Published: (2013)